Peregrine Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-171,291
| Closed | -$9.16M | – | 340 |
|
|
2020
Q4 | $9.16M | Sell |
171,291
-16,798
| -9% | -$898K | 0.17% | 236 |
|
|
2020
Q3 | $7.76M | Sell |
188,089
-37,568
| -17% | -$1.55M | 0.21% | 158 |
|
|
2020
Q2 | $10.9M | Sell |
225,657
-183,297
| -45% | -$8.88M | 0.31% | 123 |
|
|
2020
Q1 | $17.3M | Buy |
408,954
+37,177
| +10% | +$1.57M | 0.62% | 54 |
|
|
2019
Q4 | $15.9M | Sell |
371,777
-22,476
| -6% | -$962K | 0.41% | 114 |
|
|
2019
Q3 | $14.2M | Sell |
394,253
-144,025
| -27% | -$5.18M | 0.39% | 118 |
|
|
2019
Q2 | $14.4M | Sell |
538,278
-1,166
| -0.2% | -$31.2K | 0.36% | 125 |
|
|
2019
Q1 | $14.5M | Sell |
539,444
-140,161
| -21% | -$3.76M | 0.36% | 126 |
|
|
2018
Q4 | $11M | Sell |
679,605
-73,709
| -10% | -$1.19M | 0.31% | 135 |
|
|
2018
Q3 | $15.6M | Buy |
+753,314
| New | +$15.6M | 0.37% | 124 |
|